1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Veterans: new trials by email Literature Review of Veterans trials Research Report on Veterans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca - Chronic Insomnia, Sleep Deprivation | Phase 1 | Not yet recruiting | Nyree Penn | 100 | 2025-11-01 | 2025-05-28 |
| Warrior CARE: Cannabis Behavioral Health Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use | Phase 1 / Phase 2 | Recruiting | Wayne State University | 500 | 2025-09-22 | 2026-08-07 |
Stress Disorders, Post-Traumatic (2) · Alzheimer Disease (1) · Anxiety Disorders (1) · Cancer Pain (1) · Chronobiology Disorders (1) · Combat Disorders (1) · Depression (1) · Idiopathic Hypersomnia (1) · Marijuana Abuse (1) · Pain (1) · Psychological Well-Being (1) · REM Sleep Behavior Disorder (1) · Sleep Deprivation (1) · Sleep Disorders, Circadian Rhythm (1) · Sleep Initiation and Maintenance Disorders (1)
Behavior (2) · Behavioral Symptoms (2) · Mental Disorders (2) · Stress Disorders, Traumatic (2) · Trauma and Stressor Related Disorders (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Dementia (1) · Disorders of Excessive Somnolence (1) · Dyssomnias (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1)
Cannabidiol (1) · Dronabinol (1) · Electroencephalography (1) · Propofol (1)
Nyree Penn (1) · Wayne State University (1)
United States (2)